North America Immunohistochemistry Market Dynamics and Trends by 2028

The North America immunohistochemistry market is expected to grow from US$ 838.05 million in 2021 to US$ 1,405.86 million by 2028; it is estimated to grow at a CAGR of 7.7% from 2021 to 2028.

The US, Canada, and Mexico are economies in North America. Growing incidences of chronic and infectious diseases is expected to escalate the market growth. Immunohistochemistry (IHC) refers to an important application monoclonal and polyclonal antibody for tissue determination and distribution of antigens of particular disease. It is majorly used to detect several infectious disorders like dengue, hepatitis, human immunodeficiency virus (HIV). Chronic medical conditions such as obesity, cancer, diabetes, heart disease, and stroke, are also considered to be the primary major applications of immunohistochemistry that helps in the diagnosis of these diseases. Diabetes is prevailing at a high rate in the geriatric population across the region. The prevalence of diabetes is more in overweight and obese people. The obesity rates have been increasing rapidly in developed as well as developing economies across the region. Factors such as unhealthy lifestyle and sedentary life are among the major for the rise in the number of obese individuals. Cardiovascular diseases (CVDs) include cerebrovascular disease, rheumatic heart disease, coronary heart disease, and other conditions. It is the most significant cause of morbidity and mortality across the region. Furthermore, there has been a rise in cancer incidence and mortality rates all over the region, making cancer the leading cause of death. Such an increase in the incidence of chronic and infectious diseases is expected to create a demand for immunoassay tests around the North America region.

Countries in North America, especially the US, are highly affected due to the COVID-19 outbreak. Various healthcare research centers across the country are focused on COVID-19 treatments. The outbreak pandemic has adversely affected economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. The COVID-19 crisis has overburdened public health systems in many countries and highlighted the strong need for sustainable investment in health systems. As the pandemic progresses, the healthcare industry is expected to see a drop in growth. The life sciences segment thrives due to increasing demand for invitro diagnostic products and rising research and development activities in North America. However, the medical technologies and imaging segment is witnessing drop in sales due to a smaller number of surgeries being carried out amid the outbreak and delayed or prolonged procurement of equipment. Additionally, virtual consultations by healthcare professionals are expected to become the mainstream care delivery model post-pandemic. With telehealth transforming care delivery, digital health will continue to thrive in coming years. In addition, disrupted clinical trials and the subsequent delay in drug launches are expected to pave the way for entirely virtual trials in the future. New technologies, such as mRNA, are expected to drive the pharmaceutical industry. Thus, the market is expected to witness vertical integration and joint ventures in coming years. 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the North America immunohistochemistry market. The North America immunohistochemistry market is expected to grow at a good CAGR during the forecast period. 

North America Immunohistochemistry Market Segmentation  

North America Immunohistochemistry Market – By Product

• Equipment
  • Slide Staining Systems
  • Tissue Microarray Systems
  • Tissue Processing Systems
  • Slide Scanners
  • Other Equipment
• Antibodies
  • Primary Antibodies
  • Secondary Antibodies
• Reagents
  • Histological Stains
  • Blocking and Fixation Reagents
  • Chromogenic Substrates
  • Fixation Reagents
  • Stabilizers
  • Organic Solvents
  • Proteolytic Enzymes
  • Diluents
• Kits

North America Immunohistochemistry Market – By Application

• Diagnostics
  • Cancer
  • Infectious Diseases
  • Autoimmune Diseases
  • Diabetes Mellitus
  • Nephrological Diseases
  • Others
• Drug Testing

North America Immunohistochemistry Market – By End User

• Hospitals and Diagnostic Laboratories
• Research Institutes
• Others

North America Immunohistochemistry Market, by Country

• US 
• Canada   
• Mexico

North America Immunohistochemistry Market - Companies Mentioned

• Abcam plc
• Agilent Technologies, Inc.
• Bio SB
• BIO-RAD LABORATORIES INC.
• Cell Signaling Technology, Inc.  
• Danaher
• F. HOFFMANN-LA ROCHE LTD.
• MERCK KGaA
• PerkinElmer Inc.
• THERMO FISHER SCIENTIFIC INC.

North America Immunohistochemistry Report Scope